Oberlin, OH, United States of America

David Wilson


 

Average Co-Inventor Count = 16.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Oberlin, OH (US) (2013)
  • Brooklyn, NY (US) (2013)

Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of David Wilson

Introduction

David Wilson is a notable inventor based in Oberlin, OH (US), recognized for his significant contributions to the field of medicinal chemistry. With a total of 2 patents to his name, Wilson has focused on developing novel compounds that address critical health issues.

Latest Patents

Wilson's latest patents include cyclic benzimidazole derivatives that are useful as anti-diabetic agents. These novel compounds are activators of AMP-protein kinase and are designed to treat, prevent, and suppress diseases mediated by the AMPK-activated protein kinase. Specifically, these compounds are beneficial in the treatment of Type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and hypertension.

Career Highlights

Throughout his career, Wilson has worked with prominent companies such as Merck Sharp & Dohme Corporation and Metabasis Therapeutics, Inc. His work in these organizations has contributed to advancements in pharmaceutical research and development.

Collaborations

Wilson has collaborated with notable colleagues, including Brett C Bookser and Qun Dang, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

David Wilson's innovative work in developing anti-diabetic agents showcases his commitment to addressing significant health challenges. His contributions to medicinal chemistry continue to influence the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…